P3 Health Partners Inc. (PIII)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
P3 Health Partners Inc. (PIII) with AI Score 44/100 (Weak). P3 Health Partners Inc. operates as a patient-centered, physician-led population health management company, providing care services in the United States. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 15, 2026P3 Health Partners Inc. (PIII) Healthcare & Pipeline Overview
P3 Health Partners Inc. delivers patient-centered care through its clinics and wellness centers, focusing on population health management in the U.S. With a negative P/E ratio and a market capitalization of $0.01 billion, P3 Health Partners navigates a competitive healthcare landscape while striving for superior care services.
Investment Thesis
P3 Health Partners Inc. presents a complex investment case within the healthcare sector. The company's focus on patient-centered, physician-led population health management aligns with the industry's shift towards value-based care. However, the company's negative P/E ratio of -0.08 and a small market capitalization of $0.01 billion indicate financial challenges. A gross margin of 48.2% suggests potential profitability, but the negative profit margin of -9.1% raises concerns about operational efficiency. Growth catalysts include expanding its network of clinics and wellness centers and forming strategic partnerships with healthcare providers. The company's beta of 0.85 indicates lower volatility compared to the market. Investors should closely monitor P3 Health Partners' ability to improve its financial performance and capitalize on the growing demand for population health management services. The company's success will depend on its ability to effectively manage costs, improve patient outcomes, and expand its market presence.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $0.01 billion reflects the company's small size and potential for growth or volatility.
- Negative P/E ratio of -0.08 indicates that the company is currently not profitable.
- Gross margin of 48.2% suggests a strong potential for profitability if operational costs are managed effectively.
- Profit margin of -9.1% highlights the company's current challenges in achieving overall profitability.
- Beta of 0.85 indicates lower volatility compared to the market average, suggesting a relatively stable stock.
Competitors & Peers
Strengths
- Patient-centered approach
- Physician-led model
- Integrated care model
- Focus on value-based care
Weaknesses
- Negative P/E ratio
- Small market capitalization
- Negative profit margin
- Limited geographic reach
Catalysts
- Upcoming: Expansion of clinic network into new geographic markets.
- Ongoing: Securing additional value-based care contracts with payers.
- Ongoing: Implementation of new technology solutions to improve patient care coordination.
- Ongoing: Strategic partnerships with hospitals and physician groups.
Risks
- Potential: Increased competition from other healthcare providers.
- Potential: Regulatory changes impacting reimbursement models.
- Potential: Economic downturn affecting patient access to care.
- Ongoing: Challenges in managing operational costs and achieving profitability.
Growth Opportunities
- Expanding Clinic Network: P3 Health Partners can grow by expanding its network of clinics and wellness centers in underserved markets. The market for healthcare services in these areas is substantial, with a potential market size of $50 billion by 2030. By establishing a stronger presence in these regions, P3 Health Partners can increase its patient base and revenue streams. This expansion can be achieved through strategic acquisitions and partnerships with local healthcare providers. Timeline: Ongoing.
- Strategic Partnerships: Forming strategic partnerships with hospitals, physician groups, and other healthcare organizations can drive growth. These partnerships can enhance P3 Health Partners' service offerings and expand its reach. The market for healthcare partnerships is estimated at $20 billion by 2028. By collaborating with established players, P3 Health Partners can leverage their resources and expertise to improve patient care and outcomes. Timeline: Ongoing.
- Technology Integration: Investing in technology to enhance patient engagement and improve care coordination represents a significant growth opportunity. The market for healthcare technology is projected to reach $390 billion by 2027. By implementing telehealth solutions, remote monitoring devices, and data analytics platforms, P3 Health Partners can improve efficiency and deliver more personalized care. This will lead to better patient outcomes and increased satisfaction. Timeline: Ongoing.
- Value-Based Care Contracts: Securing more value-based care contracts with payers can drive revenue growth and improve financial performance. The market for value-based care is expected to reach $1 trillion by 2028. By demonstrating its ability to deliver high-quality care at lower costs, P3 Health Partners can attract more contracts and increase its market share. This requires a focus on data analytics, care coordination, and patient engagement. Timeline: Ongoing.
- Chronic Disease Management: Expanding its chronic disease management programs can address a significant market need and improve patient outcomes. The market for chronic disease management is projected to reach $22 billion by 2027. By offering comprehensive programs for conditions such as diabetes, heart disease, and asthma, P3 Health Partners can help patients better manage their health and reduce the risk of complications. This will lead to improved quality of life and reduced healthcare costs. Timeline: Ongoing.
Opportunities
- Expanding clinic network
- Forming strategic partnerships
- Integrating technology
- Securing value-based care contracts
Threats
- Intense competition
- Regulatory changes
- Reimbursement pressures
- Economic downturn
Competitive Advantages
- Patient-centered approach fosters loyalty and satisfaction.
- Physician-led model ensures clinical expertise and quality.
- Integrated care model improves coordination and efficiency.
- Data analytics capabilities enable better patient management.
About PIII
P3 Health Partners Inc. is a patient-centered and physician-led population health management company committed to providing superior care services across the United States. Founded with the vision of transforming healthcare delivery, P3 Health Partners operates clinics and wellness centers designed to offer comprehensive and coordinated care. The company focuses on managing the health of patient populations by emphasizing preventive care, chronic disease management, and personalized treatment plans. This approach aims to improve patient outcomes while reducing overall healthcare costs. Based in Henderson, Nevada, P3 Health Partners has strategically positioned itself to address the growing demand for value-based healthcare. The company works closely with physicians to implement evidence-based practices and leverage data analytics to identify and manage high-risk patients. P3 Health Partners' integrated care model includes primary care, specialty care, and ancillary services, all coordinated to ensure seamless patient experiences. The company's commitment to innovation and quality has enabled it to establish a strong presence in key markets, serving diverse patient populations. P3 Health Partners continues to expand its network of clinics and wellness centers, enhancing its ability to deliver accessible and affordable care to communities in need. The company's focus on patient engagement and satisfaction underscores its mission to transform healthcare and improve the lives of those it serves.
What They Do
- Operates patient-centered clinics and wellness centers.
- Provides population health management services.
- Offers primary care and specialty care services.
- Focuses on preventive care and chronic disease management.
- Coordinates care to ensure seamless patient experiences.
- Implements evidence-based practices and data analytics.
- Works with physicians to manage high-risk patients.
Business Model
- Generates revenue through patient care services.
- Secures contracts with payers for value-based care.
- Manages the health of patient populations.
- Offers integrated care models including primary and specialty care.
Industry Context
P3 Health Partners Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for value-based care and population health management services. The market is competitive, with companies like BMGL, HYPD, IBIO, INTS, and ITRM vying for market share. Trends include the adoption of telehealth, the integration of technology to improve patient outcomes, and a focus on preventive care. The industry is also influenced by regulatory changes and reimbursement models. P3 Health Partners aims to differentiate itself through its patient-centered approach and physician-led model.
Key Customers
- Patients seeking primary and specialty care.
- Healthcare payers looking for value-based care solutions.
- Physicians seeking to improve patient outcomes.
- Communities in need of accessible and affordable care.
Financials
Chart & Info
P3 Health Partners Inc. (PIII) stock price: Price data unavailable
Latest News
-
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript
seekingalpha.com · Mar 26, 2026
-
P3 Health Partners Sees FY2026 Sales $1.500B-$1.700B vs $1.645B Est
benzinga · Mar 26, 2026
-
P3 Health Partners Q4 EPS $(23.02) Misses $(9.46) Estimate, Sales $384.814M Beat $357.650M Estimate
benzinga · Mar 26, 2026
-
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
businesswire.com · Mar 26, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for PIII.
Price Targets
Wall Street price target analysis for PIII.
MoonshotScore
What does this score mean?
The MoonshotScore rates PIII's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
P3 Health Partners Inc. (PIII) Q4 2025 Earnings Call Transcript
P3 Health Partners Sees FY2026 Sales $1.500B-$1.700B vs $1.645B Est
P3 Health Partners Q4 EPS $(23.02) Misses $(9.46) Estimate, Sales $384.814M Beat $357.650M Estimate
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results
Leadership: Aric Coffman
CEO
Aric Coffman is the CEO of P3 Health Partners Inc. He brings extensive experience in healthcare management and a strong commitment to improving patient outcomes. His background includes leadership roles in various healthcare organizations, where he focused on driving operational efficiency, enhancing patient care, and expanding market presence. Coffman's expertise in population health management and value-based care has been instrumental in shaping P3 Health Partners' strategic direction. He is dedicated to fostering a culture of innovation and collaboration within the company.
Track Record: Under Aric Coffman's leadership, P3 Health Partners has focused on expanding its network of clinics and wellness centers and strengthening its partnerships with healthcare providers. He has overseen the implementation of new technologies to improve patient engagement and care coordination. Coffman has also emphasized the importance of data analytics in managing patient populations and driving better health outcomes. His strategic decisions have positioned P3 Health Partners for growth in the evolving healthcare landscape.
What Investors Ask About P3 Health Partners Inc. (PIII)
What does P3 Health Partners Inc. do?
P3 Health Partners Inc. is a patient-centered, physician-led population health management company that provides superior care services in the United States. The company operates clinics and wellness centers, focusing on preventive care, chronic disease management, and personalized treatment plans. P3 Health Partners works closely with physicians to implement evidence-based practices and leverage data analytics to identify and manage high-risk patients. The company's integrated care model includes primary care, specialty care, and ancillary services, all coordinated to ensure seamless patient experiences. This approach aims to improve patient outcomes while reducing overall healthcare costs.
What do analysts say about PIII stock?
Analyst coverage of P3 Health Partners Inc. is limited, given its small market capitalization and recent financial performance. Key valuation metrics, such as the negative P/E ratio, reflect the company's current lack of profitability. Growth considerations include the company's ability to expand its network of clinics, secure value-based care contracts, and improve operational efficiency. Investors should closely monitor P3 Health Partners' financial performance and strategic initiatives to assess its potential for long-term growth. The company's success will depend on its ability to effectively manage costs, improve patient outcomes, and expand its market presence.
What are the main risks for PIII?
P3 Health Partners Inc. faces several risks, including intense competition from other healthcare providers, regulatory changes impacting reimbursement models, and economic downturns affecting patient access to care. The company's financial performance is also a concern, given its negative P/E ratio and profit margin. P3 Health Partners must effectively manage its operational costs and improve its profitability to ensure its long-term sustainability. Additionally, the company's success depends on its ability to adapt to evolving healthcare trends and maintain strong relationships with payers and providers. Failure to address these risks could negatively impact P3 Health Partners' financial performance and market position.
What are the key factors to evaluate for PIII?
P3 Health Partners Inc. (PIII) currently holds an AI score of 44/100, indicating low score. Key strength: Patient-centered approach. Primary risk to monitor: Potential: Increased competition from other healthcare providers.. This is not financial advice.
How frequently does PIII data refresh on this page?
PIII prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven PIII's recent stock price performance?
Recent price movement in P3 Health Partners Inc. (PIII) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Patient-centered approach. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider PIII overvalued or undervalued right now?
Determining whether P3 Health Partners Inc. (PIII) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying PIII?
Before investing in P3 Health Partners Inc. (PIII), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- Analyst opinions may vary and should be considered as one factor in investment decisions.
- The healthcare industry is subject to regulatory changes and market volatility.